Xiao-shan Zhang
Jinhua, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Model-based dosing optimization and therapeutic drug monitoring practices of teicoplanin in patients with complicated or non-complicated methicillin-resistant staphylococcus aureus infection.
Journal: British journal of clinical pharmacology
Published: June 07, 2023
Correction to: Efficacy and Pharmacodynamic Target Attainment for Ceftazidime-Avibactam Off-Label Dose Regimens in Patients with Continuous or Intermittent Venovenous Hemodialysis: Two Case Reports.
Journal: Infectious diseases and therapy
Published: November 05, 2022
Modification of Vancomycin Dosing in Cardiac Surgery With Cardiopulmonary Bypass.
Journal: Journal of clinical pharmacology
Published: August 26, 2022
Population pharmacokinetic analysis, renal safety, and dosing optimization of polymyxin B in lung transplant recipients with pneumonia: A prospective study.
Journal: Frontiers in pharmacology
Published: August 15, 2022
Population Pharmacokinetics of Colistin Sulfate in Critically Ill Patients: Exposure and Clinical Efficacy.
Journal: Frontiers in pharmacology
Published: April 08, 2022
Dosage Strategy of Linezolid According to the Trough Concentration Target and Renal Function in Chinese Critically Ill Patients.
Journal: Frontiers in pharmacology
Published: January 12, 2022
Efficacy and Pharmacodynamic Target Attainment for Ceftazidime-Avibactam Off-Label Dose Regimens in Patients with Continuous or Intermittent Venovenous Hemodialysis: Two Case Reports.
Journal: Infectious diseases and therapy
Published: January 07, 2022
Intraventricular colistin sulphate as a last resort therapy in a patient with multidrug-resistant Acinetobacter baumannii induced post-neurosurgical ventriculitis.
Journal: British journal of clinical pharmacology
Published: August 16, 2021
Model Based Identification of Linezolid Exposure-toxicity Thresholds in Hospitalized Patients.
Journal: Frontiers in pharmacology
Published: June 29, 2021
Trough polymyxin B plasma concentration is an independent risk factor for its nephrotoxicity.
Journal: British journal of clinical pharmacology
Published: April 21, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026